Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 2005

View Archived Issues

Methylene blue increases brain oxygen consumption and facilitates memory retention in rats

Neuroprotective effects of S-34176, a free radical scavenger

Chronic gamma-secretase blockade safe and beneficial in experimental AD / News in Context

TheraQuest pain drug candidates investigated in preclinical, clinical studies

(-)-BPAP HCl neuroprotective in organotypic slice cultures

A phase III trial finds no efficacy for edifoligide in the prevention of CABG failure

NuvaRing reported as effective as an oral combination of contraceptives

Clinical evidence supports the use of laquinimod in multiple sclerosis

Gaboxadol shows promise in the treatment of insomnia in elderly subjects

Studies reveal therapeutic value of pregabalin in treating neuropathic pain

ALGRX-4975 reduces pain in osteoarthritis, bunionectomy

Orphan medicinal product status for TGN-1412 in Europe

Maruho and Toray Industries to jointly develop TRK-820 in Japan

Topical anesthesia with ALGRX-3268 tested in children undergoing venipuncture

Keppra effective in adjunctive treatment of myoclonic seizures

Sativex improves pain and symptoms in multiple sclerosis

Serono licenses Syntonix' technologies to develop inhalable interferon-beta:Fc

New patents disclose therapeutic agents for cancer

Novel immunomodulatory agents disclosed by CNRS and INSERM

Recent patents describe new antiinfective compounds

Past Tysabri patient had PML

ImmunoGen submits IND for huC242-DM4

Aeras and Statens Serum Institut team up on TB vaccine development

Enrollment completed in U.S. Fluviral study

ExCel study to investigate ability of exemestane to prevent breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...